Nasonex and Ceftriaxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Ceftriaxone (ceftriaxone sodium). Common drug interactions include back pain among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Ceftriaxone. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.



On Jul, 11, 2026

71 people who take Nasonex and Ceftriaxone together, and have interactions are studied.

Nasonex and Ceftriaxone drug interactions.

What are the common drug interactions of Nasonex and Ceftriaxone, by gender? *:

female:

  1. Back pain
  2. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  3. Bone marrow failure
  4. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  5. Dental discomfort
  6. Fat tissue increased
  7. Foot fracture
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Intervertebral disc protrusion (spinal disc protrusion)
  10. Mastication disorder (disease of chewing food)

male:

  1. Pneumonia
  2. Arthralgia (joint pain)
  3. Osteomyelitis (infection of bone)
  4. Pain in extremity
  5. Skin lesion
  6. Abdominal pain
  7. Asthenia (weakness)
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Insomnia (sleeplessness)

What are the common drug interactions of Nasonex and Ceftriaxone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Rhinovirus infection
  2. Influenza
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Upper respiratory tract infection
  5. Aggression
  6. Agitation (state of anxiety or nervous excitement)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Hepatic enzyme increased
  9. Partial seizures (seizures which affect only a part of the brain at onset)
  10. Postoperative thrombosis (formation of a blood clot inside a blood vessel after operative)

20-29:

  1. Abdominal pain
  2. Diarrhoea
  3. Drug hypersensitivity
  4. Pyrexia (fever)

30-39:

  1. Acute respiratory failure
  2. Tracheomalacia (a structural abnormality of the tracheal (windpipe) cartilage resulting in the collapse of the wall of the trachea which obstructs the airway)
  3. Pneumonia

40-49:

  1. Injury
  2. Pain
  3. Anxiety
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Emotional distress
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Influenza
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Arthralgia (joint pain)
  10. Back pain

50-59:

  1. Antinuclear antibody positive
  2. Back pain
  3. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  4. Bone marrow failure
  5. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  6. Dental discomfort
  7. Fat tissue increased
  8. Foot fracture
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Intervertebral disc protrusion (spinal disc protrusion)

60+:

  1. Anaemia (lack of blood)
  2. Fall
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Lumbar vertebral fracture
  5. Pain in extremity
  6. Pleural effusion (water on the lungs)
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Renal failure chronic (long lasting kidney dysfunction)
  10. Anxiety

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 15 people, 21.13%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 19.72%
  3. Immunodeficiency Common Variable: 14 people, 19.72%
  4. Pneumonia: 7 people, 9.86%
  5. The Flu (the flu is caused by an influenza virus): 6 people, 8.45%
  6. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 6 people, 8.45%
  7. Dehydration (dryness resulting from the removal of water): 6 people, 8.45%
  8. High Blood Pressure: 6 people, 8.45%
  9. Upper Respiratory Tract Infection: 6 people, 8.45%
  10. Parainfluenzae Virus Infection: 6 people, 8.45%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Ceftriaxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasonex and Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftriaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate and ceftriaxone sodium (the active ingredients of Nasonex and Ceftriaxone, respectively), and Nasonex and Ceftriaxone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: